Navigation Links
Protalix BioTherapeutics, Inc. Receives Approval from the FDA to,Initiate a Phase III Clinical Trial of prGCD

Protalix BioTherapeutics, Inc.

Protalix's proprietary technology is based on its plant cell culture and bioreactor system, which provides an effective and scaleable cell system for industrial production of recombinant biopharmaceuticals. Protalix is pursuing advanced clinical studies for its enzyme therapy for Gaucher Disease and intends to advance additional recombinant biopharmaceutical drug development programs. The Company believes its plant-based expression has significant advantages over more traditional mammalian and bacterial expression technology with respect to patient safety, cost and scalability.

Safe Harbor Statement

To the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, the inherent risks and uncertainties in developing drug platforms and products of the type we are developing; delays in our preparation and filing of applications for regulatory approval; delays in the approval or potential rejection of any applications we file with the FDA, or other health regulatory authorities; lack of progress of our research and development (including the results of clinical trials being conducted by us); obtaining on a timely basis sufficient patient enrollment in our clinical trials; the impact of development of competing therapies and/or technologies by other companies; our ability to obtain additional financings required to fund our research programs; our
'"/>




Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
3. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
4. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
5. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:10/31/2014)... October 31, 2014 Today, Analysts ... CELG ), Bristol-Myers Squibb Co. (NYSE: ... UNH ), Sanofi SA (NYSE: SNY ) ... these notes ahead of publication. To reserve complementary membership, ... ,-- ,Celgene Corporation Research Reports ,On October 23, 2014, ...
(Date:10/31/2014)... , Oct. 31, 2014  Zacks.com announces the list of ... Research analysts discuss the latest news and events impacting stocks and ... (Nasdaq: AMGN - Free Report ), Celgene (Nasdaq: ... BIIB - Free Report ), Market Vectors Biotech ... SPDR S&P Biotech ETF (AMEX: XBI - Free ...
(Date:10/31/2014)... , November 3, 2014 ... for men with BPH to discuss "male orgasmic dysfunction" ... shows ability to treat prostate symptoms while preserving sexual ... today welcomes the publication of a paper in the ... suffering from enlarged prostate to discuss with their doctors ...
Breaking Medicine Technology:Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 2Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 3Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 4Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 5Financial Results, Acquisition Agreement, and Legal Issue Update - Research Reports on Celgene, Bristol-Myers, UnitedHealth, Sanofi and Actavis 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2
...  ViroPharma Incorporated (NASDAQ: VPHM ) today announced ... drug Plenadren ® (hydrocortisone, modified release tablet) were ... (JCEM), a leading scientific journal for endocrinology. Plenadren was ... insufficiency in adults. The authors described results ...
... SANTA MONICA, Calif., Feb. 16, 2012 GoodRx ... prescription drug price comparison technology that provides consumers with accurate ... both a website and free iphone app ... greatly between competing pharmacies, and find discounts, free coupons and ...
Cached Medicine Technology:Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 2Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 3Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 4Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 5Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified Release Tablet) in Adrenal Insufficiency Published in the Journal of Clinical Endocrinology and Metabolism 6GoodRx™ Brings Price Transparency to Prescription Drugs 2GoodRx™ Brings Price Transparency to Prescription Drugs 3GoodRx™ Brings Price Transparency to Prescription Drugs 4
(Date:11/1/2014)... 2014 On Saturday, November 15, 2014, ... walk at Hugh Taylor Birch State Park in Fort ... retinal diseases. According to the Foundation Fighting Blindness ... Usher syndrome are currently affecting more than 10 million ... , leading national retailer of assistive technology for the ...
(Date:11/1/2014)... Haelle HealthDay Reporter FRIDAY, ... adult anger and alter their behavior in response to it, ... co-author Andrew Meltzoff, co-director of the University of Washington Institute ... only from their own direct social experiences but from watching ... he was most surprised at how emotionally "sophisticated" the babies ...
(Date:10/31/2014)... Branch, TX (PRWEB) October 31, 2014 ... in preparation for winter. Many quality electric space heaters ... is stocking the superior Broan-Nutone Big Heat 1500w portable ... which is newly available at TheHardwareCity.com, offers an energy ... house or cabin. The ceramic heating elements produce 1500 ...
(Date:10/31/2014)... The process of cell division is central to life. ... each other, has fascinated scientists since the dawn of ... long, it has been notoriously difficult to study this ... before cleaving in two. , The name given to ... "cell movement" and captures the sense of a highly ...
(Date:10/31/2014)... In the first study of its kind, Rice University ... circuits that cause cancer cells to become metastatic. The ... allows cancer cells to both migrate and form new ... to new drugs that interfere with the genetic switches ... cells and circulating tumor cells -- two of the ...
Breaking Medicine News(10 mins):Health News:Lesa Kretschmer, CEO of Florida Reading & Vision Technology, Inc. Named Event Chair of the Foundation Fighting Blindness 2014 South Florida VisionWalk 2Health News:Lesa Kretschmer, CEO of Florida Reading & Vision Technology, Inc. Named Event Chair of the Foundation Fighting Blindness 2014 South Florida VisionWalk 3Health News:Study Shows How Toddlers Adjust to Adult Anger 2Health News:Study Shows How Toddlers Adjust to Adult Anger 3Health News:Big Heat 1500w Electric Space Heater Now Available at TheHardwareCity.com 2Health News:Cell division, minus the cells 2Health News:Cell division, minus the cells 3Health News:Decoding the emergence of metastatic cancer stem cells 2Health News:Decoding the emergence of metastatic cancer stem cells 3
... have a choice when it comes to their bowel cancer ... to the launch// of the first Australian national bowel cancer ... and harms of alternate screening methods, the Government decided not ... ,Eligible people turning 55 or 65 this year will be ...
... that experimental dietary regimens can calm and even ... which appears in the July 2006 issue of ... to show that restricting caloric intake, specifically carbohydrates, ... brain associated with longevity. ,“Both clinical and ...
... Consultants Association which recently appointed a new president has ... mind among consultants//. ,Dr Mary Mc Caffrey, ... "There is nothing to be gained by a consultant ... staff are not also present. The reforms we need ...
... British baby who was born blind was successfully operated//. ... second youngest child in the world to undergo the surgery. He ... the surgery in the New York State. , James ... surgery on the kid said that there were no complications. ...
... evidence of the consistent ingenuity displayed by China, has ... have also devised a new technology that will help ... by the Ministry of Agriculture. National Avian Influenza Reference ... ,The ministry is hopeful of the powerful defensive mechanism ...
... American Medical Association has backed a tax penalty for uninsured ... not to//. This number has been estimated to be about ... already been considering legislation towards this issue in Congress and ... voting in favor of individual responsibility comes close on its ...
Cached Medicine News:Health News:Choosing your Bowel Cancer Test 2Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 2Health News:Restriction of Carbohydrates to Prevent Alzheimer's Disease 3Health News:AMA Supports Tax Penalty for Uninsured Americans 2
Acuvue Toric is an exceptionally comfortable soft contact lens made especially for people with astigmatism. The Acuvue Toric lens is designed to comfortably fit the unique shape of your eye....
C 2.3K with lightweight headband: the practical alternative for spectacle-wearers. Delivered in protective designer case....
... Vitrasert implant is a device that ... Aids-related Cytomegalovirus (CMV) Retinitis. This approach ... when compared with conventional intravenous treatment. ... in a polymer-based system that slowly ...
Near PT test card/illus of the ocular adnexa 5 1/2" X 8"....
Medicine Products: